CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial Risk Stratification Guided by the Index of Microcirculatory Resistance and Left Ventricular End-Diastolic Pressure in Acute Myocardial Infarction Coronary CT Angiography and 5-Year Risk of Myocardial Infarction Chronic total occlusion intervention of the non-infarct-related artery in acute myocardial infarction patients: the Korean multicenter chronic total occlusion registry Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress

LetterJuly 31, 2018 Vol 138, Issue 5

JOURNAL:Circulation. Article Link

Response by Kaier et al to Letter Regarding Article, “Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction”

TE Kaier , R Twerenbold , C Puelacher et al. Keywords: cMyC; cardiac myosin-binding protein C; myocardial infarction, APACE; troponin I; troponin T

ARTICLE LINK

Please click on the "Article Link" to read the full content.